Small Bowel Cancer: Clinical Trials

2 trials for Small Bowel Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 2
Phase 21Active not recruiting 1

Follow Small Bowel Cancer: new trials by email Literature Review of Small Bowel Cancer trials Research Report on Small Bowel Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
IMT-009, Fruquintinib - Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2Active not recruitingImmunitas Therapeutics672022-11-282025-10-16
Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
PIPAC with Nal-IRI - Peritoneal Carcinomatosis, Peritoneal Metastases
Phase 1Active not recruitingUniversity Hospital, Ghent452022-11-212026-07-13

Narrower conditions

Colorectal Neoplasms (2)  ·  Appendiceal Neoplasms (1)  ·  Bile Duct Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cholangiocarcinoma (1)  ·  Esophageal Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Lymphoma (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Pancreatic Neoplasms (1)  ·  Peritoneal Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)

Broader conditions

Carcinoma (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Rectal Diseases (2)  ·  Abdominal Neoplasms (1)  ·  Adenocarcinoma (1)

Interventions

HMPL-013 (1)  ·  irinotecan sucrosofate (1)

Sponsors

Immunitas Therapeutics (1)  ·  University Hospital, Ghent (1)

Countries

Belgium (1)  ·  United States (1)

Top investigators

Wim P Ceelen, MD, PhD, Prof (1)